Skip to content
10-Q

Quarterly Report

ABIOMED INC

0001564590-21-041562

← back to feed
Filed
Aug 5, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2022 · Jul 30, 2021 45.38M sh
Cash And Equivalents Q1 2022 · Jun 30, 2021 $175.45M
Cash And Equivalents Q1 2022 · Mar 31, 2021 $232.71M
Current Liabilities Q1 2022 · Jun 30, 2021 $113.12M
Current Liabilities Q1 2022 · Mar 31, 2021 $128.97M
Total Liabilities Q1 2022 · Jun 30, 2021 $150.87M
Total Liabilities Q1 2022 · Mar 31, 2021 $164.68M
Current Assets Q1 2022 · Jun 30, 2021 $729.87M
Current Assets Q1 2022 · Mar 31, 2021 $787.97M
Total Assets Q1 2022 · Jun 30, 2021 $1.46B
Total Assets Q1 2022 · Mar 31, 2021 $1.49B
Shares Diluted Q1 2022 · Jun 30, 2020 45.55M sh
Stock Repurchased Q1 2022 · Jun 30, 2020 $11.31M
Capex Q1 2022 · Jun 30, 2020 $10.04M
Operating Cash Flow Q1 2022 · Jun 30, 2020 $31.76M
Stockholders Equity Q1 2022 · Jun 30, 2020 $1.1B
Stockholders Equity Q1 2022 · Mar 31, 2020 $1.07B
Eps Diluted Q1 2022 · Jun 30, 2020 $0.98
Eps Basic Q1 2022 · Jun 30, 2020 $0.99
Sga Expense Q1 2022 · Jun 30, 2020 $68.44M
Rd Expense Q1 2022 · Jun 30, 2020 $26.36M
Net Income Q1 2022 · Jun 30, 2020 $44.59M
Operating Income Q1 2022 · Jun 30, 2020 $34.07M
Revenue Q1 2022 · Jun 30, 2020 $164.85M